Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pol J Vet Sci ; 25(1): 5-12, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35575768

RESUMO

In this study, the cryoprotective effect of different doses of propolis (P) on bull semen, which has solid pharmacological properties thanks to its rich phenolic components, was investigated biochemically and physiologically. Semen samples were collected from Simmental breed bulls via the artificial vagina and pooled. After dividing into five groups, control (C: no additive) and four different P (200, 100, 50, and 25 µg/mL) groups, the final concentration was diluted to 16×106 per straw. Semen samples were equilibrated at 4°C for approximately 4 hours, then placed in French straws and frozen. After thawing, sperm motility and kinetic parameters, DNA integrity by single-cell gel electrophoresis, sperm abnormalities by liquid fixation, and lipid peroxidation levels by the colorimetric method was analyzed by Computer-Assisted Semen Analyzer. P added to the diluent showed no effect on motility and kinetic parameters at P25 and P50 (p>0.05), while P100 and P200 had a negative effect (p⟨0.001). The addition of P (25 and 50) showed a treatment effect on tail abnormality compared to C (p⟨0.05). Especially P50 had a positive effect on tail length, tail DNA, and tail movement, while P100 and P200 caused DNA damage (p⟨0.001). MDA levels increased in all P dose groups compared to C (p⟨0.001). This study has clearly demonstrated that P25 and P50 supplements could be used therapeutically to treat sperm tail abnormalities and prevent DNA damage in post-thawed bull sperm.


Assuntos
Própole , Preservação do Sêmen , Animais , Bovinos , Criopreservação/veterinária , Crioprotetores/farmacologia , DNA , Feminino , Masculino , Própole/farmacologia , Sêmen , Análise do Sêmen/veterinária , Preservação do Sêmen/métodos , Preservação do Sêmen/veterinária , Motilidade dos Espermatozoides , Espermatozoides/fisiologia
2.
Neoplasma ; 57(6): 512-21, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20845989

RESUMO

UNLABELLED: Several polymorphisms in cytochrome P-450s (CYP)s and Glutathione S-transferases (GST)s have been reported to be associated with survival rates of patients with non-small cell lung cancer (NSCLC) but the studies in this regard are scarce and the results are contradictory. In this study, CYP1A1 (Ile462Val), CYP1B1(Asn453Ser), GST M1, GSTP1 exon 5 (Ile105Val) and exon 6(Ala114Val) and GSTT1 polymorphisms were determined in 138 patients with advanced NSCLC to evaluate their role in survival. Of the studied CYP and GST polymorphisms only GSTP1 exon 6 variant significantly altered (improved) the survival compared to wild type (p=0.036) with median survival of 22.2 months and 16.1 months, respectively. Multivariate analysis also revealed a significant reduction of adjusted hazard ratio of death associated only with the GSTP1 exon 6 variant genotype of 0.45 (95% confidence interval (95% CI), 0.23-0.89, p=0.022). These results show that the GSTP1 exon 6 variant genotype is associated with improved survival in the patients with advanced NSCLC. KEYWORDS: Cytochrome P-450, glutathione S-transferase, non small cell lung cancer, polymorphism, survival.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/genética , Citocromo P-450 CYP1A1/genética , Sistema Enzimático do Citocromo P-450/genética , Glutationa Transferase/genética , Neoplasias Pulmonares/genética , Polimorfismo Genético , Adulto , Idoso , Hidrocarboneto de Aril Hidroxilases , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Citocromo P-450 CYP1B1 , Feminino , Glutationa S-Transferase pi/genética , Humanos , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade
3.
Adv Ther ; 23(1): 23-32, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16644604

RESUMO

This story investigated the effects of interferon-alpha-2b (IFN-alpha2b) on the optic nerves of 17 adult male Wistar albino rats. Animals were divided into 3 groups: 6 rats (group 1) received 7.5 units (5 mIU/m2) IFN-alpha2b-a normal treatment dose, and 6 (groups 2) received 30.0 units (20 mIU/m2)-a high dose; 5 rats (control group) received 0.5 mL saline. Test substances were delivered by intraperitoneal injection 3 times a week for 3 weeks with animals under inhalation anesthesia. After the rats were sacrificed, their optic nerves were dissected, sectioned, and examined under an electron microscope. The mean thicknesses of the basal membranes of blood vessels were 86.354 nm in the control group, 104.297 nm in group 1, and 140.181 nm in group 2. Basal membrane changes in IFN groups were dose dependent. Mitochondrial swelling, degeneration, increased diameter of vacuoles, and vacuolization in the cytoplasm of oligodendrocytes and astrocytes were also observed. IFN-alpha2b has histopathologic effects on blood vessels and cells of the optic nerve.


Assuntos
Interferon-alfa/efeitos adversos , Bainha de Mielina/efeitos dos fármacos , Nervo Óptico/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Interferon alfa-2 , Masculino , Bainha de Mielina/patologia , Bainha de Mielina/ultraestrutura , Nervo Óptico/irrigação sanguínea , Nervo Óptico/patologia , Ratos , Proteínas Recombinantes
4.
Sarcoidosis Vasc Diffuse Lung Dis ; 17(3): 292-6, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11033847

RESUMO

Diffuse panbronchiolitis (DPB) is a distinct clinicopathological entity which is characterized by chronic recurrent sinopulmonary infection and inflammation. It is prevalent in the Far East, but extremely rare in western countries. In this report, we described the first Turkish case of DPB and also evaluated demographic and diagnostic characteristics of 18 patients with DPB, previously reported from non-Asian countries. We believe that DPB patients described from these countries may also increase if this disease is taken into consideration in differential diagnosis of sinopulmonary diseases. Another consideration is that, since the treatment and prognosis of DPB are different from other obstructive pulmonary diseases, it should not be mistaken for others.


Assuntos
Bronquiolite/complicações , Bronquiolite/patologia , Sinusite/complicações , Adulto , Biópsia por Agulha , Gasometria , Bronquiolite/diagnóstico , Bronquiolite/tratamento farmacológico , Broncoscopia , Seguimentos , Humanos , Masculino , Recidiva , Roxitromicina/administração & dosagem , Sinusite/diagnóstico , Sinusite/tratamento farmacológico , Tomografia Computadorizada por Raios X , Turquia
5.
Auris Nasus Larynx ; 27(4): 323-6, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10996490

RESUMO

INTRODUCTION: Experimental infection of adults with influenza A virus, rhinovirus or RSV causes abnormal ME pressure in some, but not all subjects. The hypothesis tested in this study is that the response variability is caused by constitutional differences in the functioning of the Eustachian tube. METHODS: 18 adult subjects were experimentally infected with influenza A virus. On five occasions before virus exposure, middle ear pressure (by tympanometry) and Eustachian tube function (by sonotubometry) were recorded bilaterally. Tests were repeated on days 1 through 8 and 10 after infection. Individual ears were classified with respect to the number of pre-exposure, positive sonotubometric testings and the middle ear pressure response to infection was compared between ears with Eustachian tube openings at all pre-infection test sessions (GR-A) and those with at least one negative test (GR-B). RESULTS: Pre-exposure, 19, six, four, four, one and two ears had tubal openings on five, four, three, two, one and zero sessions, respectively. For that period, GR-A had significantly lesser average intra-ear and intra-group middle ear pressure variances compared to GR-B, but there were no between-group differences in the average middle ear pressure or in the number of observations of abnormal middle ear pressure. After virus exposure, middle ear pressure variances and the number of abnormal observations increased and the average pressure decreased in both groups, but the effects were more pronounced for GR-B ears. CONCLUSIONS: These results support the hypothesis that pre-existing good Eustachian tube function reduces the otological complications of viral upper respiratory tract infection.


Assuntos
Orelha Média/fisiopatologia , Tuba Auditiva/fisiopatologia , Vírus da Influenza A , Influenza Humana/fisiopatologia , Adulto , Humanos , Vírus da Influenza A/fisiologia , Influenza Humana/virologia , Pressão , Eliminação de Partículas Virais
6.
Arch Otolaryngol Head Neck Surg ; 126(2): 165-73, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10680867

RESUMO

OBJECTIVES: To investigate the safety and efficacy of a topical combination of tobramycin and dexamethasone in a primate model of chronic suppurative otitis media (CSOM) and to explore the contribution of the added topical steroid for the treatment of CSOM. DESIGN: Blinded, randomized, placebo-controlled trial. SUBJECTS: Sixty juvenile cynomolgus monkeys randomized into the following 6 treatment groups of 10 monkeys each: 0.3% tobramycin (group 1), combined 0.3% tobramycin-0.1% dexamethasone (group 2), combined 1.0% tobramycin-0.33% dexamethasone (group 3), 0.1% dexamethasone (group 4), vehicle (group 5), and phosphate-buffered saline solution (group 6). INTERVENTIONS: Chronic suppurative otitis media was established by inoculating the right ear with Pseudomonas aeruginosa. After 4 weeks of drainage, animals were treated according to the group assignment with 3 drops twice daily for 7 weeks. Hearing thresholds were monitored with repeated auditory brainstem response testing (ABR), and clinical response was monitored with repeated otoscopic examinations and cultures throughout the study. Cytocochleograms were evaluated for quantification of outer hair cell loss. RESULTS: Rapid resolution of otorrhea and eradication of P aeruginosa occurred in all groups receiving tobramycin. The inclusion of dexamethasone accelerated the resolution of otorrhea and negative yields of cultures compared with tobramycin alone. Otorrhea and positive culture findings persisted in the groups not treated with topical antibiotic. Results of ABRs at 4 and 8 weeks and cytocochleograms for outer cell hair loss were not affected by drug administration. Perilymph samples collected at the end of the study showed no detectable tobramycin. CONCLUSIONS: Combined tobramycin-dexamethasone ear drops were safe and effective in the monkey CSOM model. Dexamethasone enhanced the efficacy of tobramycin.


Assuntos
Antibacterianos/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Dexametasona/administração & dosagem , Otite Média Supurativa/tratamento farmacológico , Infecções por Pseudomonas/tratamento farmacológico , Tobramicina/administração & dosagem , Administração Tópica , Animais , Antibacterianos/farmacocinética , Anti-Inflamatórios/farmacocinética , Limiar Auditivo , Doença Crônica , Cóclea/patologia , Dexametasona/farmacocinética , Avaliação de Medicamentos , Orelha Média/patologia , Potenciais Evocados Auditivos , Glucocorticoides , Macaca fascicularis , Otite Média Supurativa/diagnóstico , Otite Média Supurativa/microbiologia , Otite Média Supurativa/patologia , Perilinfa/química , Infecções por Pseudomonas/microbiologia , Infecções por Pseudomonas/patologia , Pseudomonas aeruginosa/isolamento & purificação , Distribuição Aleatória , Tobramicina/farmacocinética
7.
Audiology ; 37(1): 52-8, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9474439

RESUMO

Sudden hearing loss is a clinical entity which has numerous aetiologies. In cases where the aetiology is not determined, evaluation and treatment of sudden hearing loss are very difficult. A case of probable multiple sclerosis with sudden hearing loss as the initial symptom is reported. The pure-tone audiometry showed a quasi-total sensorineural hearing loss in the left ear; the left side displayed only wave I in the auditory brainstem response (ABR). Electronystagmographic examination revealed hypometric dysmetria and saccadic pursuit abnormalities. Magnetic resonance imaging (MRI) showed high-intensity lesions with multiple foci. After steroid therapy, the patient's hearing loss, vertigo and visual problems improved, but the ABR findings remained unchanged. We have decided to present this case because of the interesting ABR finding revealing the presence of wave I and the absence of all other waves after the normalization of the hearing.


Assuntos
Perda Auditiva Neurossensorial/etiologia , Esclerose Múltipla/complicações , Adulto , Anti-Inflamatórios/uso terapêutico , Audiometria de Tons Puros , Encéfalo/patologia , Potenciais Evocados Auditivos do Tronco Encefálico , Feminino , Perda Auditiva Neurossensorial/diagnóstico , Humanos , Imageamento por Ressonância Magnética , Esclerose Múltipla/tratamento farmacológico , Esclerose Múltipla/patologia , Índice de Gravidade de Doença , Esteroides
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA